Alnylam Pharmaceuticals reported $3.51B in Assets for its second fiscal quarter of 2021.


Ok
Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
width
height
Assets Change
Acadia Pharmaceuticals ACAD:US $ 724.43M 30.74M
Agios Pharmaceuticals AGIO:US $ 1874.6M 613.83M
Alexion Pharmaceuticals ALXN:US $ 18650.2M 547.2M
Alnylam Pharmaceuticals ALNY:US $ 3509.43M 254.16M
Amgen AMGN:US $ 59773M 2766M
Arena Pharmaceuticals ARNA:US $ 1084.66M 99.28M
Arrowhead Research ARWR:US $ 734.93M 21.87M
Avrobio Inc AVRO:US $ 238.1M 7.82M
Biocryst Pharmaceuticals BCRX:US $ 277.28M 7.15M
Biomarin Pharmaceutical BMRN:US $ 5898.5M 93.44M
Bluebird Bio BLUE:US $ 1454.46M 182.82M
Dicerna Pharmaceuticals DRNA:US $ 838.49M 155.08M
Gw Pharmaceuticals GWPH:US $ 934.34M 5.17M
Intercept Pharmaceuticals ICPT:US $ 523.22M 3.11M
IONIS PHARMACEUT IONS:US $ 2497.07M 248.52M
Mirati Therapeutics MRTX:US $ 1355.7M 25.14M
Moderna Inc MRNA:US 16.15B 3.46B
Neurocrine Biosciences NBIX:US $ 1956.4M 110M
Novartis NVS:US $ 124015M 2263M
Ptc Therapeutics PTCT:US $ 2058.67M 53.27M
Regeneron Pharmaceuticals REGN:US $ 21485.9M 3713.7M
Regulus Therapeutics RGLS:US $ 49.52M 9.68M
Sangamo Biosciences SGMO:US $ 835.36M 41.73M
Sarepta Therapeutics SRPT:US $ 2759.07M 6.16M
Takeda 4502:JP Y 12657234M 255059M
Ultragenyx Pharmaceutical RARE:US $ 1512.44M 85.32M
Vertex Pharmaceuticals VRTX:US $ 12221.69M 106.63M
Xencor XNCR:US $ 695.6M 2.86M
YTE INCY:US $ 3904.62M 243.19M